Saltar al contenido
Merck

793558

Sodium iodide

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño


Acerca de este artículo

Fórmula lineal:
NaI
Número CAS:
Peso molecular:
149.89
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-679-3
MDL number:
Assay:
≥99%
Grade:
anhydrous
Form:
powder
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Nombre del producto

Sodium iodide, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

InChI key

FVAUCKIRQBBSSJ-UHFFFAOYSA-M

InChI

1S/HI.Na/h1H;/q;+1/p-1

SMILES string

[Na+].[I-]

grade

anhydrous

vapor density

>1 (vs air)

product line

ReagentPlus®
Redi-Dri

assay

≥99%

form

powder

quality

free-flowing

impurities

≤1.0% water

pH

6-9 (20 °C, 50 g/L)

mp

661 °C (lit.)

Quality Level

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Application

Sodium iodide can be used as an iodine precursor salt to synthesize semi-organic nonlinear optical single crystal of bis thiourea sodium iodide (BTSI) via slow evaporation solvent technique.

General description

Sodium iodide is an inorganic sodium salt. It is used as an iodinating agent in organic synthesis to prepare various iodine-containing compounds. It is used in the conversion of alkyl halides and sulfonates into alkyl iodides and aryl iodides via nucleophilic displacement reactions. Additionally, sodium iodide is also used in combination with oxidizing agents for the iodination of organoboranes, phenols, and aromatic compounds.

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

Clase de almacenamiento

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Brian A Rabe et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(39), 24450-24458 (2020-09-10)
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had an enormous impact on society worldwide, threatening the lives and livelihoods of many. The effects will continue to grow and worsen if economies begin to open without the
P E N Braad et al.
Physics in medicine and biology, 60(13), 5297-5312 (2015-06-26)
Peri-therapeutic (124)I-PET/CT is of interest as guidance for radioiodine therapy. Unfortunately, image quality is complicated by dead time effects and increased random coincidence rates from high (131)I-activities. A series of phantom experiments with clinically relevant (124)I/(131)I-activities were performed on a
Kohei Sano et al.
Biochemical and biophysical research communications, 464(3), 820-825 (2015-07-15)
Photoacoustic (PA) imaging is an attractive imaging modality for sensitive and depth imaging of biomolecules with high resolution in vivo. The aim of this study was to evaluate the effectiveness of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (panitumumab; Pan)
Anke de Vries et al.
Investigative radiology, 50(4), 297-304 (2015-01-01)
The objective of this study was to investigate the feasibility and the accuracy of spectral computed tomography (spectral CT) to determine the tissue concentrations and localization of high-attenuation, iodine-based contrast agents in mice. Iodine tissue concentrations determined with spectral CT
Mohamed Touati et al.
Leukemia & lymphoma, 56(2), 332-341 (2014-04-29)
Finding new prognostic factors to identify patients with Hodgkin lymphoma (HL) at risk of treatment resistance or relapse remains challenging in daily practice. We evaluated the relationship between CD68 expression, interim positron emission tomography (iPET) results and outcome in 158

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico